£515.00

It has never been this cheap. We have no record of a lower price.

£515 today · cheaper than every other day in the last 3 months

The 2023-2028 Outlook for Premature Ejaculation Treatments in India

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 29 days · 29 data points (no recent data)

Historical
Generating forecast…
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 31 July 2026 07 August 2026 14 August 2026 21 August 2026 28 August 2026
View at Amazon ↗

Price data last checked 62 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 29 days • 1 price levels

Days at Price
29 days 0 7 15 22 29 £515 Days at Price

Price Analysis

Most common price: £515 (29 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 29 days

Description
This study covers the latent demand outlook for premature ejaculation treatments across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the city is of its state or union territory and of India as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state, union territory, and city, latent demand estimates are created for premature ejaculation treatments. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of premature ejaculation treatments as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Absorption Pharmaceuticals, Allergan, AstraZeneca, Bayer, Eli Lilly and Company, GlaxoSmithKline, Innovus Pharmaceuticals, Merck & Company, Pfizer, and Teva Pharmaceutical Industries. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications
Format
paperback
ASIN
B0BGKQTTF6
Category
Books > Subjects
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
29 September 2022

Similar Products You Might Like

The 2023-2028 Outlook for Premature Ejaculation Treatments in the United States
99% match

The 2023-2028 Outlook for Premature Ejaculation Treatments in the United States

£520.00 03 Sep 2026
The 2023-2028 Outlook for Premature Ejaculation Treatments for US Zip Codes
99% match

The 2023-2028 Outlook for Premature Ejaculation Treatments for US Zip Codes

£490.00 02 Sep 2026
The 2025-2030 World Outlook for Premature Ejaculation Treatments
99% match

The 2025-2030 World Outlook for Premature Ejaculation Treatments

Price unavailable
The 2023-2028 World Outlook for Premature Ejaculation Treatments
99% match

The 2023-2028 World Outlook for Premature Ejaculation Treatments

Price unavailable
The 2023 Report on Premature Ejaculation Treatments: World Market Segmentation by City
98% match

The 2023 Report on Premature Ejaculation Treatments: World Market Segmentation by City

£795.00 28 Oct 2026
The 2023-2028 World Outlook for Pain-Relieving Lidocaine Patches
96% match

The 2023-2028 World Outlook for Pain-Relieving Lidocaine Patches

£795.00 12 Aug 2026
Medical Disorders and Sexual Health: A Guide for Healthcare Providers (Trends in Andrology and Sexual Medicine)
95% match

Medical Disorders and Sexual Health: A Guide for Healthcare Providers (Trends in Andrology and Sexual Medicine)

Springer

£95.42 13 Aug 2026
The 2023-2028 Outlook for Nocturia Drugs in China
95% match

The 2023-2028 Outlook for Nocturia Drugs in China

£495.00 02 Sep 2026
Premature Ejaculation: Theory, Evaluation and Therapeutic Treatment
95% match

Premature Ejaculation: Theory, Evaluation and Therapeutic Treatment

Routledge

£145.22 17 Oct 2026
Zeitgemäße Therapie der erektilen Dysfunktion
95% match

Zeitgemäße Therapie der erektilen Dysfunktion

Springer

£64.81 11 Sep 2026
Men's Health 4e
95% match

Men's Health 4e

CRC Press

£227.08 29 Oct 2026
The 2023-2028 Outlook for Bioengineered Monoclonal Antibodies Protein Drugs in Japan
95% match

The 2023-2028 Outlook for Bioengineered Monoclonal Antibodies Protein Drugs in Japan

£495.00 13 Aug 2026
The Textbook of Clinical Sexual Medicine
95% match

The Textbook of Clinical Sexual Medicine

Springer

£169.89 07 Sep 2026
Hardon Blue 10 Tablets - Herbal Performance Supplement for Men
95% match

Hardon Blue 10 Tablets - Herbal Performance Supplement for Men

Hardon Blue

£9.95 11 Feb 2026
The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in China
95% match

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in China

£495.00 05 Sep 2026
Glocal Pharma: International Brands and Local Masculinity
95% match

Glocal Pharma: International Brands and Local Masculinity

Routledge

£123.56 11 Oct 2026
The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs for US Zip Codes
95% match

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs for US Zip Codes

£490.00 03 Sep 2026
Hormonal Therapy for Male Sexual Dysfunction: 1 (SMIP - Sexual Medicine in Practice)
95% match

Hormonal Therapy for Male Sexual Dysfunction: 1 (SMIP - Sexual Medicine in Practice)

Wiley

£61.60 10 Sep 2026
Bioenvironmental Issues Men's Reproductive Health - Academic Press
95% match

Bioenvironmental Issues Men's Reproductive Health - Academic Press

Elsevier

£158.99 02 Oct 2026
The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in India
95% match

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in India

£515.00 28 Oct 2026
The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in Japan
95% match

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in Japan

£495.00 03 Sep 2026
The 2025-2030 World Outlook for Peripheral Neuropathy Treatments
95% match

The 2025-2030 World Outlook for Peripheral Neuropathy Treatments

Price unavailable
Family Practice Guidelines
95% match

Family Practice Guidelines

Springer Publishing Company

£106.99 24 Sep 2026
The 2026-2031 World Outlook for High Potency APIs (HPAPIs)
95% match

The 2026-2031 World Outlook for High Potency APIs (HPAPIs)

£885.00 23 Aug 2026